Acumen Hypotension Prediction Index (HPI) Feature Software vs Study Watch
AI Verdict
Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…
Choose Acumen HPI if your primary need is real-time, predictive monitoring to prevent hypotensive events in acute care settings. This tool is ideal for anesthesiologists, critical care, and emergency medicine clinicians who require early alerts and insights into hemodynamic instability to proactively manage patients and improve outcomes during surgery or in the ICU.
View Acumen Hypotension Prediction Index (HPI) Feature Software →Choose Study Watch if…
Choose Verily Study Watch if your objective is to conduct long-term, non-invasive physiological data collection for clinical research and the development of AI-enabled health solutions. This wearable device is best suited for researchers in cardiology, neurology, and sleep medicine who need continuous, multi-sensor data capture over extended periods in a research context.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | Study Watch |
|---|---|---|
| Deployment | Unknown | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI is integrated directly into Edwards Lifesciences' HemoSphere advanced monitoring platform, providing real-time, actionable insights like the HPI score and Smart Alerts within existing clinical workflows. Study Watch, while easy to wear, is a data collection device for research, requiring data upload and analysis in a separate cloud platform, making its direct usability for immediate clinical decision-making less direct.
Clinical Value
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI has a demonstrated clinical outcome: a reduction in the incidence, duration, and severity of intraoperative hypotension, predicting events up to 15 minutes in advance. Study Watch is primarily a data collection tool for clinical research, which can inform future care, but does not offer direct, real-time, and proven clinical intervention for a specific condition in the same manner.
Pricing & Value
TieNeither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Their value propositions also differ significantly, with Acumen HPI focusing on immediate clinical outcomes and Study Watch on comprehensive data collection for research.
Enterprise Readiness
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI is designed for integration into an existing advanced monitoring platform (HemoSphere), suggesting a streamlined deployment within hospital infrastructure. While both companies are large and have FDA clearance, Verily's Study Watch faces an ongoing lawsuit alleging HIPAA and BAA breaches, which, despite denials, could present a potential concern for enterprise adoption.
Innovation
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI is described as a 'first-of-its-kind technology' for its predictive capability, using machine learning to forecast hypotensive events up to 15 minutes before they occur, enabling proactive clinical intervention. While Study Watch is innovative in its comprehensive, continuous physiological data collection via a wearable, HPI's direct, real-time predictive application of AI for a critical clinical event represents a more immediate and impactful innovation for patient care.
Support & Docs
TieThe provided structured facts do not contain specific details regarding the support and documentation for either tool. While both Edwards Lifesciences and Verily are large, established companies expected to offer robust support, there is insufficient comparative information to determine a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | Study Watch |
|---|---|---|
| Name | Acumen Hypotension Prediction Index (HPI) Feature Software | Study Watch |
| Company | Edwards Lifesciences | Verily Life Sciences |
| Primary Function | Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis. |
| Categories | Cardiology AI, Triage & ER/ICU AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Anesthesiology, Critical Care, Emergency Medicine | Cardiology, Neurology, Sleep Medicine |
| Key Features (Examples) | Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen for impending hypotensive events, Predicts hypotension up to 15 minutes before an event. | Continuous physiological monitoring (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), On-demand single-channel ECG, Irregular pulse monitor. |
Videos
Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Study Watch.